2m 2m 2m 2m 2m 2m 2m
CITIUS ONCO (CTOR)
NASDAQ
$0.58-$0.12 (-16.65%)
Price as of Oct 23, 2026 6:22 PM EDT- $74.0MMarket Cap
- -58.11%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
CITIUS ONCO (CTOR)
$0.58-$0.12 (-16.65%)
CTOR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.70 | ||
Change | -$0.0008 (-0.11%) | ||
Open | $0.73 | ||
High | $0.73 | ||
Low | $0.66 | ||
Previous Close | $0.70 | ||
Volume | 38,020 | ||
30-Day Average Volume | 75,034 | ||
1-Week Change | -6.23% | ||
1-Month Change | -34.63% | ||
1-Year Change | -58.11% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 105.8M | ||
Total Assets | $112.1M | ||
Market Cap | $74.0M | ||
Enterprise Value | $63.8M | ||
Period: QTR TTM FY | |||
Revenue | $1.5M | ||
Net Income | -$8.9M | ||
Free Cash Flow | -$2.7M | ||
EBIT | -$8.8M | ||
EBITDA | -$8.8M | ||
Net Working Capital | -$16.1M | ||
EPS | -$0.08 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | 43 | ||
P/B | 2 | ||
P/E | -9 | ||
PEG | -0 | ||
Price/Free Cash Flow | -27 | ||
Price/Operating Cash Flow | -27 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||